TLR4 and Nephropathy: Pharmacological inhibition of TLR4 and/or associated pro-inflammatory signalling has been vastly undertaken to better understand the signalling mechanisms driving kidney damage (Niu et al., 2019; González-Guerrero et al., 2017; Shi et al., 2017).